Olin (OLN) Q1 2026 earnings review
Earnings Crater YoY, But Q2 Guidance Signals a Rebound
Olin experienced a brutal Q1 2026 relative to the prior year, with Net Income swinging to an $83 million loss and Adjusted EBITDA plummeting 53% YoY to $86.2 million. However, management successfully framed this as a 'sequential improvement' from a disastrous 25Q4 trough, beating their own pessimistic guidance. The most alarming break in trend came from the Chlor Alkali (CAPV) segment, which swung to a $44.5M loss burdened by lower pricing and a $36M litigation charge. Conversely, the Epoxy segment validated its restructuring efforts, drastically narrowing its segment loss despite lackluster demand. Looking ahead, geopolitical supply shocks (Iran conflict) are acting as an unexpected catalyst, prompting management to guide for a massive sequential acceleration in Q2 Adjusted EBITDA to $160-$200 million.
🐂 Bull Case
The highly publicized Stade, Germany restructuring is bearing fruit. The Epoxy segment returned to positive Adjusted EBITDA, vastly outperforming the deep losses sustained throughout 2025.
Global supply shortages stemming from the Iran conflict have tightened trade flows, allowing Olin's advantaged North American asset base to aggressively capture higher pricing and volumes heading into Q2.
🐻 Bear Case
The core cash engine broke down. CAPV swung from a $78.3M profit a year ago to a $44.5M loss, hammered by lower pricing, higher gas/power costs, and the unwinding of the Blue Water Alliance.
Net debt to Adjusted EBITDA ratio ballooned to a perilous 5.1x, up from 3.5x a year ago, fueled by negative operating cash flows and cratering trailing-twelve-month earnings.
⚖️ Verdict: ⚪
Neutral. While the YoY headline numbers are undeniably toxic, Olin exceeded its own gloomy Q1 expectations and provided a surprisingly robust Q2 guide. The cycle may have finally bottomed, but the severely elevated leverage limits the margin for error.
Key Themes
Contradicting Narrative: 'Sequential Improvement' Masks Deep YoY Decay
Management touted that 'the Olin team delivered sequential improvement in adjusted EBITDA.' While mathematically true vs a catastrophic 25Q4 ($86.2M vs $67.7M), this narrative masks a severe structural breakdown compared to a year ago. Adjusted EBITDA is down 53% YoY, and Net Income reversed from a $1.4M profit to an $83M loss. Celebrating this quarter highlights how drastically the baseline expectations have deteriorated.
Epoxy Restructuring Delivers Immediate Relief
After a grueling 2025, the Epoxy segment reversed its trajectory. Despite only a 7% YoY increase in sales, segment pre-tax losses narrowed dramatically from $28.4M to $2.9M, returning to positive Adjusted EBITDA. Management explicitly credited the Beyond250 structural cost actions and the new supply agreement at the Stade, Germany facility.
Winchester's Profitless Prosperity
A massive divergence emerged in the Winchester segment. Sales jumped 21% YoY to $470.5M, but segment earnings plummeted 33% to $15.2M. This reversing margin profile indicates severe negative operating leverage, as price increases utterly failed to offset soaring commodity metal and raw material costs.
Macro Geopolitics: Iran Conflict Acts as a Catalyst
Management explicitly cited the late-Q1 onset of the Iran conflict as a catalyst for global supply shortages. This external macro shock is tightening trade flows, raising feedstock costs globally, and disproportionately benefiting Olin's advantaged North American asset base. This is the primary driver behind the aggressive Q2 profitability guide.
CAPV Structural Volume Loss
The conclusion of the Blue Water Alliance joint venture at the end of 2025 resulted in a sudden structural drop in CAPV trading volumes. Combined with weak pricing and high energy costs, the segment's earnings went from a $78.3M profit to a $44.5M loss YoY. Even excluding a $36.1M legacy litigation charge, the segment's fundamental profitability is deeply impaired.
Winchester Military Pivot Gaining Traction
The multi-year strategic pivot toward military and defense modernization (highlighted in prior quarters by the Next-Generation Squad Weapon project and Lake City contract) continues to bear fruit. The robust 21% sales growth in Winchester was explicitly driven by higher military project revenue and military sales, structurally offsetting the heavily destocked commercial channels.
Other KPIs
Leverage is accelerating rapidly. The ratio ballooned from 3.5x a year ago and 4.1x at the end of 2025. With a net debt load of $2.8 billion and crashing trailing-twelve-month EBITDA ($552.4M), Olin's balance sheet flexibility is becoming severely constrained.
Cash generation reversed sharply into negative territory compared to a +$81.0M cash inflow in the prior year. Working capital was a $56.8 million drag, putting further pressure on liquidity during the cyclical trough.
Guidance
Accelerating significantly versus the $86.2M posted in Q1. The midpoint ($180M) implies a return to baseline profitability, matching the $176M generated in 25Q2. Management expects this surge to be driven by seasonally stronger demand, improved pricing in Chemicals, and global supply shortages.
Accelerating. Specifically, ethylene dichloride (EDC), caustic soda, and epoxy resins are all forecasted to achieve higher pricing in Q2 as global supply remains restricted.
Accelerating. Supported by improving commercial and military demand. Crucially, the guidance suggests they finally expect pricing measures to outpace the commodity metal cost inflation that ruined Q1 margins.
Key Questions
Winchester Margin Normalization
Winchester sales grew 21% but earnings dropped 33% due to metal inflation. How quickly do you expect your commercial pricing initiatives to catch up with copper and brass costs, and when will segment margins normalize back to historical levels?
Blue Water Alliance Termination
With the Blue Water Alliance concluded, CAPV trading volumes saw a noticeable drop. Is this structural volume loss completely resetting the revenue floor for the segment, or do you have alternative long-term EDC contracting avenues to replace it?
Iran Conflict Supply Dynamics
You cited global supply shortages from the Iran conflict as a tailwind for Q2. Are you seeing this translate into strictly opportunistic spot business, or is it allowing you to secure favorable long-term structural contracts for your North American assets?
Leverage Thresholds
Net debt to Adjusted EBITDA has surged past 5.0x. What is your maximum comfort level for this metric, and what emergency levers (e.g., dividend cuts, severe capex reductions) will you pull if Q2 fails to deliver the expected $160-$200M rebound?